Recruiting NCT06556888

Observatory of Immunological Thrombopenic Purpura in the Brest Region

— Observational Immune Thrombocytopenia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Immune Thrombocytopenia. Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: France
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Official title

Observatory of Immunological Thrombopenic Purpura in the Brest Region: Descriptive and Comparative Cross-sectional Study

Database of patients with ITP, diagnosed, treated and followed in the Brest University Hospital.

Detailed description

Creation of a global clinical and biological database for all patients diagnosed, treated and followed for ITP in the University Hospital of Brest.

UHB is the regional reference center (competence center) on hemorrhagic diseases.

Dr Pan-Petesch, who is responsible of the local competence center, is affiliated to the national sector of auto-immune cytopenias CERECAI-MARIH).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

France · 1 center

Hematology Department - Institute of Oncology and Hematology, University Hospital of Brest — Brest

NCT: NCT06556888 · 29BRC19.0089